UNRESECTABLE ESOPHAGEAL CARCINOMA
Clinical trials for UNRESECTABLE ESOPHAGEAL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new UNRESECTABLE ESOPHAGEAL CARCINOMA trials appear
Sign up with your email to follow new studies for UNRESECTABLE ESOPHAGEAL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug combo shows promise for tough stomach cancers
Disease control CompletedThis study tested a combination of two drugs, olaparib and ramucirumab, in 51 people with advanced stomach or gastroesophageal junction cancer that had spread or come back. The goal was to find the safest dose and see if the combo could shrink tumors or slow the disease. While no…
Matched conditions: UNRESECTABLE ESOPHAGEAL CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 26, 2026 11:12 UTC
-
Can a simple zinc pill ease the burden of cancer treatment?
Symptom relief CompletedThis study tested whether taking zinc supplements could improve quality of life for patients with upper gastrointestinal cancers who were receiving chemotherapy. Researchers wanted to see if preventing zinc deficiency might help patients feel better during treatment. The study in…
Matched conditions: UNRESECTABLE ESOPHAGEAL CARCINOMA
Phase: NA • Sponsor: Emory University • Aim: Symptom relief
Last updated Apr 17, 2026 16:11 UTC